Skip to main content Skip to footer

Dimension III

In recent decades, personalised therapies and pharmacogenomics have advanced substantially due to their impact on improving therapeutic individualisation by optimising the process of identifying the most effective therapy for the individual. As scientific advances continue to transform practice, the pharmacy industry remains a crucial entity in accessing, dispensing and advising on the use of said solutions tailored to the needs of each individual or treatment, including strengthening its action concerning the production of compounded medicines.1,2

1. Observatório Português dos Sistemas de Saúde (OPSS). Relatório de Primavera 2022: E agora? 2022. https://www.opssaude.pt/relatorios/relatorio-de-primavera-2022/. 2. European Medicines Agencies Network (EMA/HMA). European medicines agencies network strategy to 2025: Protecting public health at a time of rapid change. 2020. https://www.ema.europa.eu/en/documents/report/european-union-medicines-agencies-network-strategy-2025-protecting-public-health-time-rapid-change_en.pdf

Keeping up with technical and scientific developments in the personalisation of therapies, maintaining pharmacies as the key entity in accessing, dispensing and advising on the use of these solutions suited to the needs of each individual or treatment.

Strengthening the legal and regulatory framework that promotes pharmacies’ intervention in producing compounding medicines.

AXES OF DEVELOPMENT

1 Strengthening the pharmacy position as a space for health and well-being in a person’s health journey

2 Digital transformation at the service of pharmacies and people

3 Generating scientific and professional evidence in health

4 Valuing teams and the profession

5 Promoting territorial cohesion as a response to social and health determinants

6 Promoting economic and financial sustainability

AXES OF DEVELOPMENT

1 Strengthening the pharmacy position as a space for health and well-being in a person’s health journey

2 Digital transformation at the service of pharmacies and people

3 Generating scientific and professional evidence in health

4 Valuing teams and the profession

5 Promoting territorial cohesion as a response to social and health determinants

6 Promoting economic and financial sustainability

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our site and allow us to remember your preferences. We use this information to improve and personalize your browsing experience. To learn more, please see our Cookie Policy.